Increased density of CD103-positive tissue-resident memory T cells predicts favorable response to immunotherapy in oral cancers.
Immune checkpoint inhibitors (ICIs) have become an important therapeutic option for oral cancers; however, reliable biomarkers predicting treatment efficacy remain limited. In this study, we investigated the association between intratumoral immune cell subsets, regional lymph node (RLN) immune status, and clinical resp...